Physician

Abdul Rahman Halabi, M.D.

According to 2025 Medicare claims, Abdul Halabi, M.D. (NPI: 1992767578) practices interventional cardiology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48341-5023. Halabi is affiliated with the Honest ACO of Michigan LLC (ACO ID: D0236), participating under the REACH model.

Halabi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,521 traditional Medicare patients, billed 6,317 HCPCS/CPT codes, and received $364,972 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 10,895 prescription claims across 1,574 beneficiaries totaling $1,718,732 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 22 claims. Open Payments data shows 58 records totaling $18,314. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $616,468 to $364,972. In contrast, Part D prescription costs have moved sharply higher in recent years, from $367,773 to $1,718,732. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,823	6,884	$616,468
2016	1,735	6,550	$590,856
2017	1,755	7,150	$623,030
2018	1,653	7,148	$596,100
2019	1,499	7,303	$643,295
2020	1,192	5,208	$403,978
2021	1,466	6,406	$454,551
2022	1,616	6,447	$396,958
2023	1,527	5,974	$344,322
2024	1,521	6,317	$364,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	795	6,043	$367,773
2016	868	6,759	$475,298
2017	930	7,073	$548,951
2018	1,009	7,833	$668,364
2019	1,072	8,316	$828,243
2020	1,110	8,821	$975,095
2021	1,184	9,361	$1,026,736
2022	1,367	9,980	$1,186,601
2023	1,454	10,342	$1,513,280
2024	1,574	10,895	$1,718,732

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	22	22	$14,072
2018	22	22	$13,655
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	137	185	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	673	831	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	353	486	$63
99451	Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes	128	146	$26
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	767	964	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	496	35,157	$648,127
Entresto	Sacubitril/Valsartan	197	11,854	$243,879
Farxiga	Dapagliflozin Propanediol	159	10,153	$183,313
Xarelto	Rivaroxaban	137	9,978	$176,443
Repatha Sureclick	Evolocumab	115	6,300	$119,414

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$2,345	Endologix LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$15,969	CSL Behring
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$25,000	Vantis Vascular, Inc.

Explore More Providers

FAQ

What Medicare data is available for Abdul Rahman Halabi, M.D.?

Tedicare shows public-source Medicare data for Abdul Rahman Halabi, M.D. (NPI 1992767578), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Rahman Halabi, M.D. have ACO affiliation data?

Abdul Rahman Halabi, M.D. is shown with ACO affiliation data for Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Abdul Rahman Halabi, M.D.?

Abdul Rahman Halabi, M.D. is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Abdul Rahman Halabi, M.D. have Open Payments data?

Abdul Rahman Halabi, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.